By Maggie Fick and Yadarisa Shabong (Reuters) -Drugmaker AstraZeneca lifted its annual sales and profit forecast for the ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

Bitcoin's blistering rally rages on as the world's best known cryptocurrency scaled yet another record peak close to $90K ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential ...

AstraZeneca’s results were helped by resilient demand for its cancer and rare diseases medicines, after third-quarter results ...

The boss of AstraZeneca has said the group takes the probe in China that saw the detention of its president in the country ...

Astrazeneca has raised its guidance for the full year despite issues surrounding its presence in China according to today's ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to ...

AstraZeneca (AZN.L, AZN) reported third quarter profit to owners of the Parent of $1.43 billion compared to $1.37 billion, last year.

AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026 as part ...